dr. west on lurbinectedin in sclc
Published 6 years ago • 657 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:28
dr. forster on recent data with lurbinectedin in sclc
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
4:18
lurbinectedin’s role in managing sclc
-
1:54
dr. forster on next steps with lurbinectedin in sclc
-
5:31
novel therapies in small cell lung cancer (sclc): lurbinectedin
-
7:39
data on fda approved therapy for relapsed/refractory sclc
-
3:00
small-cell lung cancer: future directions in care
-
1:23
dr. liu on the potential of pembrolizumab in sclc
-
2:28
lurbinectedin for second line treatment of small cell lung cancer
-
0:49
dr. sabari on immunotherapy updates in small cell lung cancer
-
1:59
dr. lai on the results of the caspian trial in small cell lung cancer
-
2:43
dr. bunn on immunotherapy advances in small cell lung cancer
-
0:38
mary j. fidler, md, on combination lurbinectedin & checkpoint inhibitors in the treatment of sclc
-
2:15
no os benefit with lurbinectedin/doxorubicin in sclc - medpage today
-
1:37
dr. ready on the benefit of pd-l1 inhibition in sclc
-
1:50
dr. west discusses latest immunotherapy findings in lung cancer
-
0:50
efficacy and safety of lurbinectedin in elderly patients with relapsed sclc
-
1:54
dr. west discusses chemotherapy without driver mutations in nsclc
-
5:27
asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial